{"id":35189,"date":"2025-06-12T10:48:47","date_gmt":"2025-06-12T08:48:47","guid":{"rendered":"https:\/\/inmuno.es\/index.php\/2025\/06\/12\/comparative-analysis-of-the-tcr-repertoire-in-bone-marrow-cd8-t-cells-from-patients-with-acute-myeloid-leukemia-myelodysplastic-neoplasms-and-chronic-myelomonocytic-leukemia-valuekyriaki\/"},"modified":"2025-06-12T10:48:47","modified_gmt":"2025-06-12T08:48:47","slug":"comparative-analysis-of-the-tcr-repertoire-in-bone-marrow-cd8-t-cells-from-patients-with-acute-myeloid-leukemia-myelodysplastic-neoplasms-and-chronic-myelomonocytic-leukemia-valuekyriaki","status":"publish","type":"post","link":"https:\/\/inmuno.es\/index.php\/2025\/06\/12\/comparative-analysis-of-the-tcr-repertoire-in-bone-marrow-cd8-t-cells-from-patients-with-acute-myeloid-leukemia-myelodysplastic-neoplasms-and-chronic-myelomonocytic-leukemia-valuekyriaki\/","title":{"rendered":"Comparative Analysis of the TCR Repertoire in Bone Marrow CD8+ T Cells From Patients With Acute Myeloid Leukemia, Myelodysplastic Neoplasms, and Chronic Myelomonocytic Leukemia. [[{&#8220;value&#8221;:&#8221;Kyriaki Katsiki, \nAthanasios Tasis, \nAnastasia Filia, \nIoannis Kotsianidis, \nIoannis Mitroulis&#8221;}]]"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/onlinelibrary.wiley.com\/cms\/asset\/c3859746-bfa1-4d84-ad06-c2f821e5f4cf\/eji5999-gra-0001-m.png\" alt=\"Comparative Analysis of the TCR Repertoire in Bone Marrow CD8+ T Cells From Patients With Acute Myeloid Leukemia, Myelodysplastic Neoplasms, and Chronic Myelomonocytic Leukemia\" \/><\/p>\n<p>Bone marrow CD8<sup>+<\/sup> T cells from patients with MDS and CMML show decreased TCR diversity compared to AML. Treatment with the hypomethylating agent azacitidine in MDS and CMML alters TCR repertoire of CD8<sup>+<\/sup> T cells without affecting TCR diversity.<\/p>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Bone marrow CD8+ T cells from patients with MDS and CMML show decreased TCR diversity compared to AML. Treatment with the hypomethylating agent azacitidine in MDS and CMML alters TCR repertoire of CD8+ T cells without affecting TCR diversity.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[112,42],"tags":[],"class_list":["post-35189","post","type-post","status-publish","format-standard","hentry","category-european-journal-of-immunology","category-publicaciones"],"_links":{"self":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/35189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/comments?post=35189"}],"version-history":[{"count":0,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/35189\/revisions"}],"wp:attachment":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/media?parent=35189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/categories?post=35189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/tags?post=35189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}